Evidence map›Paper›PMID 26691774›Full record

ArticleScientific reports2015

Vitamin D3 pretreatment regulates renal inflammatory responses during lipopolysaccharide-induced acute kidney injury.

Shen Xu, Yuan-Hua Chen, Zhu-Xia Tan, Dong-Dong Xie, Cheng Zhang, Zhi-Hui Zhang, Hua Wang, Hui Zhao, De-Xin Yu, De-Xiang Xu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. 1,25(OH)Clinical rheumatology · 2025
    Article
  7. Article
  8. New drugs for acute kidney injury.Journal of intensive medicine · 2025
    Review
  9. Article
  10. Article
  11. Protective effects of vitamin DPharmaceutical biology · 2023
    Article
  12. Macrophage angiotensin ATAmerican journal of physiology. Renal physiology · 2023
    Article
  13. Article
  14. Article
  15. The Role of Vitamin D in SARS-CoV-2 Infection and Acute Kidney Injury.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shen XuThe Second Affiliated Hospital, Anhui Medical University, Hefei, China.
Yuan-Hua ChenDepartment of Toxicology, Anhui Medical University, Hefei, China.
Zhu-Xia TanThe Second Affiliated Hospital, Anhui Medical University, Hefei, China.
Dong-Dong XieThe Second Affiliated Hospital, Anhui Medical University, Hefei, China.
Cheng ZhangDepartment of Toxicology, Anhui Medical University, Hefei, China.
Zhi-Hui ZhangDepartment of Toxicology, Anhui Medical University, Hefei, China.
Hua WangDepartment of Toxicology, Anhui Medical University, Hefei, China.
Hui ZhaoThe Second Affiliated Hospital, Anhui Medical University, Hefei, China.
De-Xin YuThe Second Affiliated Hospital, Anhui Medical University, Hefei, China.
De-Xiang XuDepartment of Toxicology, Anhui Medical University, Hefei, China.
Anhui Medical University · CNSecond Hospital of Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D receptor (VDR) is highly expressed in human and mouse kidneys. Nevertheless, its functions remain obscure. This study investigated the effects of vitamin D3 (VitD3) pretreatment on renal inflammation during lipopolysaccharide (LPS)-induced acute kidney injury. Mice were intraperitoneally injected with LPS. In VitD3 + LPS group, mice were pretreated with VitD3 (25 μg/kg) at 48, 24 and 1 h before LPS injection. As expected, an obvious reduction of renal function and pathological damage was observed in LPS-treated mice. VitD3 pretreatment significantly alleviated LPS-induced reduction of renal function and pathological damage. Moreover, VitD3 pretreatment attenuated LPS-induced renal inflammatory cytokines, chemokines and adhesion molecules. In addition, pretreatment with 1,25(OH)2D3, the active form of VitD3, alleviated LPS-induced up-regulation of inflammatory cytokines and chemokines in human HK-2 cells, a renal tubular epithelial cell line, in a VDR-dependent manner. Further analysis showed that VitD3, which activated renal VDR, specifically repressed LPS-induced nuclear translocation of nuclear factor kappa B (NF-κB) p65 subunit in the renal tubules. LPS, which activated renal NF-κB, reciprocally suppressed renal VDR and its target gene. Moreover, VitD3 reinforced the physical interaction between renal VDR and NF-κB p65 subunit. These results provide a mechanistic explanation for VitD3-mediated anti-inflammatory activity during LPS-induced acute kidney injury.

Indexed as

Acute Kidney InjuryAnimalsCell LineChemokinesCholecalciferolCyclooxygenase 2HumansInflammationIntercellular Adhesion Molecule-1KidneyLipopolysaccharidesMaleMicep38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProtein BindingChemokinesCholecalciferolCyclooxygenase 2Intercellular Adhesion Molecule-1Lipopolysaccharidesp38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, CalcitriolRNA, Small InterferingTranscription Factor RelAVascular Cell Adhesion Molecule-1

Identifiers

PMID26691774
PMCPMC4686931
OpenAlexW2411424522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.